Ohri Manu
SEC CIK 1424683 · EDGAR
BoughtSold
Most active insiders at AXIL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Penna Thomas | Dir | — | — |
| 2 | Brown Jeffrey B. | CFO, COO, Dir | — | — |
| 3 | Ohri Manu | Dir | — | — |
| 4 | HUNDT NANCY | Dir | — | — |
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-04 | 2026-01-15 | AXIL | Axil Brands, Inc. | Ohri Manu | Dir | A - Grant | $0.00 | +5,000 | 15.0K | +50% | $0 | |
| 2025-01-13 | 2025-01-13 | AXIL | Axil Brands, Inc. | Ohri Manu | Dir | A - Grant | $0.00 | +5,000 | 10.0K | +100% | $0 | |
| 2024-02-20 | 2024-02-14 | AXIL | Axil Brands, Inc. | Ohri Manu | Dir | A - Grant | $0.00 | +5,000 | 5,001 | +500,000% | $0 | |
| I | 2023-08-15 | 2023-08-11 | GTBP | GT Biopharma, Inc. | Ohri Manu | CFO, Sec | J - Other | $0.29 | +200.0K | 300.0K | +200% | +$58.0K |
| 2023-08-15 | 2023-08-11 | GTBP | GT Biopharma, Inc. | Ohri Manu | CFO, Sec | J - Other | $0.29 | -200.0K | 0 | -100% | -$58.0K | |
| 2023-08-15 | 2023-08-11 | GTBP | GT Biopharma, Inc. | Ohri Manu | CFO, Sec | A - Grant | $0.29 | +200.0K | 200.0K | New | +$58.0K | |
| I | 2023-04-10 | 2023-04-06 | GTBP | GT Biopharma, Inc. | Ohri Manu | CFO, Sec | P - Purchase | $0.5 | +50.0K | 50.0K | New | +$25.0K |
| D | 2022-07-19 | 2022-07-15 | GTBP | GT Biopharma, Inc. | Ohri Manu | CFO, Sec | A - Grant | $0.00 | +100.0K | 100.0K | New | $0 |
| D | 2022-07-19 | 2022-07-15 | GTBP | GT Biopharma, Inc. | Ohri Manu | CFO, Sec | J - Other | $0.00 | -100.0K | 0 | -100% | $0 |
| DI | 2022-07-19 | 2022-07-15 | GTBP | GT Biopharma, Inc. | Ohri Manu | CFO, Sec | J - Other | $0.00 | +100.0K | 100.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations